Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European Countries

Ament, A.; Baltussen, R.; Duru, G.; Rigaud-Bully, C.; De Graeve, D.; Örtqvist, A.; Jönsson, B.; Verhaegen, J.; Gaillat, J.; Christie, P.; Cifre, A. Salazar; Vivas, D.; Loiseau, C.; Fedson, D. S.
August 2000
Clinical Infectious Diseases;8/1/2000, Vol. 31 Issue 2, p444
Academic Journal
Presents a study which determined the cost effectiveness of pneumococcal vaccination of older people in several Western European countries. Evidence of vaccination effectiveness against invasive pneumococcal disease; Differences in hospitalization costs for invasive pneumococcal disease; Hospital discharge diagnosis of pneumococcal pneumonia.


Related Articles

  • Pneumococcal 13 valent crm197 vaccine conjugate: Complicated pneumococcal pneumonia due to vaccine failure: 2 case reports.  // Reactions Weekly;Jun2019, Vol. 1756 Issue 1, p283 

    The article presents two case studies of patients who developed complicated pneumococcal pneumonia after pneumococcal 13 valent CRM197 vaccine conjugate failure and were hospitalized with pneumococcal pneumonia caused by serotype 14 or serotype 19A ofStreptococcus pneumoniae.

  • Immune Response to Pneumococcal Conjugate and Polysaccharide Vaccines in Otitis-Prone and Otitis-Free Children. Barnett, Elizabeth D.; Pelton, Stephen I.; Cabral, Howard J.; Eavey, Roland D.; Allen, Carole; Cunningham, Michael J.; McNamara, Eileen R.; Klein, Jerome O. // Clinical Infectious Diseases;7/1/99, Vol. 29 Issue 1, p191 

    Provides information on a study which compared responses to the pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharide vaccine to understand the roles of vaccines in the prevention of pneumococcal disease including otitis media. How the study was conducted; Results; Discussion of...

  • Pneumococcal infection rates make routine vaccine likely. Kelly, Brian // Pulse;4/21/2003, Vol. 63 Issue 16, p10 

    Reports on the government plan to include pneumococcal vaccine to the childhood immunization schedule in Great Britain. Increase in pneumococcal infection rate; Call for heightened surveillance of pneumococcal disease; Findings of government studies.

  • Pneumococcal vaccination: time to move on? Proesmans, Marijke Johanna // European Journal of Pediatrics;Nov2010, Vol. 169 Issue 11, p1435 

    The author comments on a study focusing on the surveillance of pediatric invasive pneumococcal infections in a tertiary care pediatric center in Quebec after the government-sponsored introduction of pneumococcal conjugate vaccine-7 (PCV-7) for children up to age 5 in a 2+1 schedule for infants....

  • Invasive pneumococcal disease in non-Indigenous people in north Queensland, 2001-2009. Hanna, Jeffrey N.; Humphreys, Jan L.; Murphy, Denise M.; Smith, Helen V. // Medical Journal of Australia;10/4/2010, Vol. 193 Issue 7, p392 

    The article analyzes the prevalence of invasive pneumococcal disease (IPD) among non-indigenous people before and after the provision of pneumococcal vaccines in north Queensland. Remarkable decline in average annual cases of IPD and serotype IPD was reported after the introduction of vaccines....

  • Pneumococcal Disease among Human Immunodeficiency Virus-Infected Persons: Incidence, Risk Factors, and Impact of Vaccination. Dworkin, Mark S.; Ward, John W.; Hanson, Debra L.; Jones, Jeffrey L.; Kaplan, Jonathan E. // Clinical Infectious Diseases;3/1/2001, Vol. 32 Issue 5, p794 

    Presents information on a study which investigated the risk factors and the impact of vaccination on pneumococcal disease in HIV-infected patients. Methodology; Results of the study; Discussion.

  • The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy.  // BMC Infectious Diseases;2012, Vol. 12 Issue 1, p106 

    The article presents the findings of a research conducted examining the current invasive pneumococcal disease (IPD). It explains the serotype distribution and the antimocrobial susceptibility of streptococcus (S.) pneumoniae which isolates in children aged less than five years residing in...

  • Recommendations of the Immunization Practices Advisory Committee Pneumococcal Polysaccharide Vaccine.  // JAMA: Journal of the American Medical Association;3/3/89, Vol. 261 Issue 9, p1265 

    Outlines recommendations by the Immunization Practices Advisory Committee (ACIP) on pneumococcal polysaccharide vaccine. Statistics on disease caused by Streptococcus pneumoniae in the United States; Mortality from pneumococcal disease; Formulation of pneumococcal vaccine; Vaccine efficacy;...

  • The controversy over the efficacy of pneumococcal vaccine. Andrews, Ross; Moberley, Sarah A. // CMAJ: Canadian Medical Association Journal;1/6/2009, Vol. 180 Issue 1, p18 

    The author reflects on the meta-analysis of Huss and colleagues regarding the efficacy of pneumococcal polysaccharide vaccine in adults. The author compares the present study with the Cochrane review by citing the excluded several related studies. The author argues that the exclusion of lung...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics